Skip to main content

Table 3 Comparison of tumor recurrence rates of HCC between DEB-TACE and cTACE

From: CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study

Group

Tumor recurrence

3 months

6 months

DEB-TACE (n = 24)

Local recurrence

1

4

New lesions

1

2

Overall ratea

8.3% (2/24)

16.7% (4/24)

cTACE (n = 30)

Local recurrence

9

13

New lesions

5

7

Overall ratea

33.3% (10/13)

43.3% (13/30)

Local recurrence

0.015

0.036

p value

New lesions

0.146

0.142

Overall ratea

0.028

0.036

  1. aLocal recurrence and new lesions may coexist, it means the number of patients, not the total of recurrences